These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6492410)

  • 1. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 2. [The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
    Goszcz A
    Pol Tyg Lek; 1986 Apr; 41(17):547-51. PubMed ID: 3737462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bile acids in chronic hepatopathies].
    Luciani A; Massari M; Montanari P; Nora A; Zandomeneghi R
    Minerva Med; 1986 Dec; 77(49-50):2287-92. PubMed ID: 3808385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
    Yamashita Y; Moriyasu F; Kimura T; Ono S; Kawasaki T; Tamada T; Ban N; Nakamura T; Uchino H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2651-7. PubMed ID: 3244182
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)].
    Shinozaki K
    Rinsho Byori; 1981 May; 29(5):475-7. PubMed ID: 7289113
    [No Abstract]   [Full Text] [Related]  

  • 7. Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases?
    Mazzanti R; Chiarantini E; Baronti E; Moscarella S; Arena U; Buzzelli G
    Boll Soc Ital Biol Sper; 1986 Feb; 62(2):219-26. PubMed ID: 3087392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
    Inaguma H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):289. PubMed ID: 7098117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
    Hino K; Yamamoto S; Yamashita S; Fukushima K; Ohashi K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2197. PubMed ID: 7328844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic significance of serum bile acids].
    Schwarz HP; Paumgartner G; Preisig R
    Schweiz Med Wochenschr; 1975 Apr; 105(17):533-5. PubMed ID: 1153981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bile acid concentration in serum after a test meal in hepatobiliary diseases. A comparison with quantitative liver function tests].
    Grandjean EM; Paumgartner G; Preisig R
    Schweiz Med Wochenschr; 1979 Sep; 109(35):1280-4. PubMed ID: 524095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ursodeoxycholic acid tolerance test in patients with digestive disease.
    Yamanishi Y; Kishimoto Y; Kawasaki H; Hirayama C; Ikawa S
    Gastroenterol Jpn; 1981; 16(5):472-7. PubMed ID: 7327385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum bile acid determination in liver diseases].
    Siciliano M; Lorenzin F; Milani A; Rossi L
    Ann Ital Med Int; 1990; 5(2):134-9. PubMed ID: 2248862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis.
    Collins DM; Tongeren AV; Cook HB; Campbell CB
    N Z Med J; 1979 Jun; 89(637):432-4. PubMed ID: 289016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum bile acid determination in chronic hepatitis and liver cirrhosis.
    Grigorescu M; Tăpălagă D; Dumitraşcu D; Suciu A
    Med Interne; 1980; 18(4):401-6. PubMed ID: 7455585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K; Yoneda M; Kimura A; Tamori K; Yokohama S; Sato Y; Kato T; Hasegawa T; Saito H; Aoshima M; Fujita M; Makino I
    J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver function test after nicotinic acid loading. I. A clinical study].
    Finck C; Jorke D
    Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.